Search
Search
Mahnia Madan, BSc, OD, FAAO; and Marc R. Bloomenstein, OD, FAAO
Show Description +
Mahnia Madan, BSc, OD, FAAO, president of the British Columbia Doctors of Optometry, joins Marc R. Bloomenstein, OD, FAAO, to discuss the treatment advances she looks forward to getting in Canada, such as MIEBO (perfluorohexyloctane ophthalmic solution; Bausch + Lomb) to treat dry eye disease and XDEMVY (lotilaner ophthalmic solution 0.25%; Tarsus Pharmaceuticals) for the treatment of Demodex blepharitis. She also describes the use of platelet-rich plasma, explaining how dry eye patients have benefitted from this treatment and how physicians can incorporate it into their practices.
Posted: 1/11/2024
Mahnia Madan, BSc, OD, FAAO; and Marc R. Bloomenstein, OD, FAAO
Mahnia Madan, BSc, OD, FAAO, president of the British Columbia Doctors of Optometry, joins Marc R. Bloomenstein, OD, FAAO, to discuss the treatment advances she looks forward to getting in Canada, such as MIEBO (perfluorohexyloctane ophthalmic solution; Bausch + Lomb) to treat dry eye disease and XDEMVY (lotilaner ophthalmic solution 0.25%; Tarsus Pharmaceuticals) for the treatment of Demodex blepharitis. She also describes the use of platelet-rich plasma, explaining how dry eye patients have benefitted from this treatment and how physicians can incorporate it into their practices.
Posted: 1/11/2024
Please log in to leave a comment.